Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Experts say the ACR/AAHKS 2022 guidelines for patients undergoing total hip replacement or total knee replacement have several limitations that limit the effectiveness of their recommendations.
Read Full NewsIn children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.
A population-based study finds that children with spina bifida are more likely than their peers in the general population to develop chronic kidney disease and ESRD — and to do so at younger ages.
1.
Skinny melanoma incidence is associated with vitamin D deficiency.
2.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
5.
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
1.
Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life
2.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
3.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
4.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
5.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge